ROS1 FISH Test – Accurate Genetic Testing for Targeted Cancer Therapy
AED3,750.00
The **Ros1 – Fish Test** is a highly sensitive and reliable fluorescence in situ hybridization (FISH) assay designed for the detection of **ROS1 gene rearrangements** in tumor samples. This test is crucial for identifying patients who may benefit from targeted therapies, particularly in **non-small cell lung cancer (NSCLC)**. Key features include **high specificity and accuracy**, rapid turnaround time, and **direct visualization of gene rearrangements** at the cellular level. Its benefits include **early and precise diagnosis**, enabling personalized treatment decisions and improving patient outcomes. The **unique selling point** of the Ros1 – Fish Test is its **proven clinical utility in guiding targeted therapy selection**, making it an essential tool for oncologists and pathologists in precision medicine.
Description
ROS1 – FISH Test: Precision Detection for Targeted Cancer Therapy
The ROS1 – FISH Test is a highly specialized Fluorescence In Situ Hybridization (FISH) assay designed to detect ROS1 gene rearrangements in tumor tissue. This test plays a crucial role in identifying patients who may benefit from targeted therapies, particularly tyrosine kinase inhibitors (TKIs), offering a personalized approach to cancer treatment.
### Key Features:
✔ High Sensitivity & Specificity – Utilizes dual-color break-apart probes to accurately detect ROS1 gene rearrangements, ensuring reliable and precise results.
✔ Rapid Turnaround Time – Provides fast and actionable insights, enabling oncologists to make timely treatment decisions.
✔ Clinically Validated – A gold-standard diagnostic tool recommended for non-small cell lung cancer (NSCLC) and other malignancies where ROS1 rearrangements are implicated.
✔ Tissue-Based Analysis – Performed on formalin-fixed, paraffin-embedded (FFPE) tumor samples, making it a minimally invasive and widely applicable test.
✔ Essential for Targeted Therapy Eligibility – Helps identify patients who may respond to ROS1 inhibitors such as crizotinib, entrectinib, and lorlatinib, improving treatment outcomes.
### Benefits to the Customer:
🔹 Personalized Treatment Decisions – Enables oncologists to tailor therapies based on a patient’s unique genetic profile, maximizing treatment efficacy.
🔹 Improved Prognosis & Survival Rates – Early detection of ROS1 rearrangements allows for the initiation of targeted therapies, which have shown significant clinical benefits.
🔹 Minimally Invasive & Reliable – Requires only a small tissue sample, reducing the need for additional invasive procedures.
🔹 Supports Clinical & Research Applications – A valuable tool for both **diagnostic and translational research**, contributing to advancements in precision oncology.
### Who Should Use This Test?
The ROS1 – FISH Test is recommended for:
✔ Oncologists & Pathologists seeking to identify ROS1-positive patients for targeted therapy.
✔ Patients diagnosed with NSCLC or other cancers where ROS1 rearrangements may be present.
✔ Clinical researchers exploring novel therapeutic strategies in precision medicine.
### Why Choose the ROS1 – FISH Test?
With its unparalleled accuracy, clinical relevance, and role in guiding life-changing treatments, the ROS1 – FISH Test is an indispensable tool in modern oncology. By detecting ROS1 gene rearrangements with high precision, this test empowers healthcare providers to make informed, patient-centric treatment decisions, ultimately improving outcomes and quality of life.
Unlock the power of precision medicine—book the ROS1 – FISH Test today.
Reviews
There are no reviews yet.